Get startedLog in
    Picture of PolyPeptide AG logo

    PPGN — PolyPeptide AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: Polypeptide Updates FY 2026 Guidance To 25-30% Revenue Growth, High-Teens Ebitda Margin

    Picture of PolyPeptide AG logoPolyPeptide AG
    19/07/2026 23:50
    BRIEF-Polypeptide Updates FY 2026 Guidance To 25-30% Revenue Growth, High-Teens Ebitda Margin
    July 19 (Reuters) - PolyPeptide Group AG PPGN.S:
    • POLYPEPTIDE GROUP: SAMSUNG BIOLOGICS ANNOUNCES TENDER OFFER TO ACQUIRE POLYPEPTIDE GROUP AG FOR CHF 44.31 PER SHARE
    • POLYPEPTIDE GROUP AG - UPDATES FY 2026 GUIDANCE TO 25-30% REVENUE GROWTH, HIGH-TEENS EBITDA MARGIN
    • POLYPEPTIDE GROUP AG - H1 2026 REVENUE EUR 236.6 MILLION, UP 41.6% YEAR-ON-YEAR
    Source text: ID:nEQ9cX1X2a
    Further company coverage: PPGN.S

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PolyPeptide AG

    See all news